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Activation of Dopamine Receptors in
the Nucleus Accumbens Promotes
Sucrose-Reinforced Cued Approach
Behavior
Johann du Hoffmann and Saleem M. Nicola *
Department of Neuroscience and Psychiatry, Albert Einstein College of Medicine, Bronx, NY, USA
Dopamine receptor activation in the nucleus accumbens (NAc) promotes vigorous
environmentally-cued food-seeking in hungry rats. Rats fed ad libitum, however, respond
to fewer food-predictive cues, particularly when the value of food reward is low. Here,
we investigated whether this difference could be due to differences in the degree of
dopamine receptor activation in the NAc. First, we observed that although rats given
ad libitum access to chow in their home cages approached a food receptacle in
response to reward-predictive cues, the number of such approaches declined as animals
accumulated food rewards. Intriguingly, cued approach to food occurred in clusters,
with several cued responses followed by successive non-responses. This pattern
suggested that behavior was dictated by transitions between two states, responsive
and non-responsive. Injection of D1 or D2 dopamine receptor agonists into the NAc
dose-dependently increased cue responding by promoting transitions to the responsive
state and by preventing transitions to the non-responsive state. In contrast, antagonists
of either D1 or D2 receptors promoted long bouts of non-responding by inducing
transitions to the non-responsive state and by preventing transitions to the responsive
state. Moreover, locomotor behavior during the inter-trial interval was correlated with the
responsive state, and was also increased by dopamine receptor agonists. These results
suggest that activation of NAc dopamine receptors plays an important role in regulating
the probability of approach to food under conditions of normative satiety.
Keywords: reward-seeking behavior, mesolimbic, locomotion, satiety, obesity, addiction, extinction
INTRODUCTION
For a hungry animal, the decision to respond to a food-predictive cue is a trivial one. Hungry,
well-trained animals respond to nearly every cue signaling food availability. The likelihood and
vigor of these responses, however, is lower in the normative state of satiety. What are the
neural mechanisms that set the probability of approach to food under such conditions? Because
responding to food-predictive cues in the absence of caloric need likely contributes to elevated
calorie consumption (Boulos et al., 2012; Boyland and Halford, 2013), answering this question is
an important step toward understanding both normal caloric intake and dysregulated intake in
obesity.
We began with the observation that dopamine receptor activation in the nucleus accumbens
(NAc) is critical for cued approach toward food-associated objects under conditions where
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a rat’s starting position varies from trial to trial. Under these
conditions, injection of either D1 or D2 dopamine receptor
antagonists into the NAc core reduces the proportion of cues
to which animals respond by increasing the latency to initiate
approach (Nicola, 2010). These effects result from a reduction
in the magnitude and prevalence of dopamine-dependent cue-
evoked excitations (du Hoffmann and Nicola, 2014). These
excitations, which are observed in nearly half of NAc neurons,
precede movement onset and are greater when the latency
to initiate movement is shorter (McGinty et al., 2013; du
Hoffmann and Nicola, 2014; Morrison and Nicola, 2014). One
hypothesis to explain reduced cue responding in non-food-
restricted animals is that less dopamine is released in less hungry
animals, an idea supported by electrochemical, microdialysis
and electrophysiological evidence (Ostlund et al., 2011; Branch
et al., 2013; Cone et al., 2014). Consequently, there may be
less activation of NAc dopamine receptors under conditions of
relative satiety, leading to a lower probability of responding to
food-associated cues.
To test this hypothesis, we asked whether pharmacologically
blocking and tonically activating NAc dopamine receptors in
non-food-restricted animals could, respectively, attenuate and
promote cue responding. In the experimental phase, rats had
access to food and water ad libitum in their home cages
in order to induce a state of relative satiety, which greatly
decreased the probability that animals would respond to a
given cue presentation. This lower response probability allowed
us to assess whether dopamine receptor agonists increase that
probability, which is not possible in hungry animals because
they respond to nearly every cue. We found that blocking
dopamine receptors decreased responding whereas activation of
the same receptors increased responding. These results suggest
that response probability and food seeking in relatively sated
animals is actively regulated by NAc dopamine.
MATERIALS AND METHODS
Animals
Eight male Long-Evans that weighed 275–300 g were purchased
from Harlan and singly housed on a 12 h light/ dark cycle. All
experiments were conducted in the light phase. Animal care
was identical to previously published accounts (Nicola, 2010; du
Hoffmann et al., 2011; McGinty et al., 2013; du Hoffmann and
Nicola, 2014;Morrison andNicola, 2014). Upon arrival, rats were
given 1 week of rest and were then habituated to being handled by
the experimenter. After habituation, animals were food restriced
to ∼90% of free feeding body weight prior to beginning the
initial stages of training. After the early stages of training, animals
were given free access to standard lab chow in their home cage.
All animal procedures were consistent with the U.S National
Institutes of Health Guide for the Care and Use of Laboratory
Animals and were approved by the Institutional Animal Care and
Use Committee at Albert Einstein College of Medicine.
Operant Chambers
Behavioral training took place in operant chambers (30× 25 cm)
purchased fromMed Associates. Experiments were conducted in
sound-attenuating cabinets with blue house lights illuminated.
A constant white noise (65 dB) was played within the chamber
to limit distractions from outside noise. Operant chambers were
equipped with a reward receptacle on one wall. A photobeam
located across the front of the receptacle measured receptacle
entry and exit times. A syringe pump, located outside the
chamber, was used to deliver liquid sucrose reward into the
reward receptacle. Behavioral time stamps were recorded with a
resolution of 1ms.
2CS Task Training
Animals were food restricted during the initial training stages.
The first stage of training required that the animals enter the food
receptacle, which triggered delivery of 10% liquid sucrose. After a
10 s delay to allow for reward consumption, animals had to leave
the receptacle and re-enter it in order to earn additional reward.
In subsequent training stages, delays of 20 s and then 30 s were
introduced between reward availability. Criterion performance
was set at 100 rewards earned in 1 h. After criterion performance
was established with a 30 s delay between reward availability, two
auditory cues were introduced that predicted either a small or
large reward (150 or 250 µl of 10% sucrose solution in water).
The auditory cues consisted of a siren tone (which cycled in
frequency from 4 to 8 kHz over 400ms) and an intermittent
tone (6 kHz tone on for 40ms, off for 50ms); cues were
assigned to large and small reward randomly for each rat and
the cue-reward magnitude relationship remained constant across
training and experiments for a given rat. Reward delivery was
contingent on the rat entering the reward receptacle during
the cue presentation, at which point the cue was terminated.
Cues were on for up to 5 s. The inter-trial interval was chosen
pseudorandomly from a truncated exponential distribution with
a mean of 30 s. Once animals responded to > 80% of the cues,
animals were fed ad libitum in their home cages from that point
until the end of experiments. After task performance stabilized,
the sucrose concentration of the liquid reward was reduced
from 10% to 3%; the volumes were not changed. Behavior was
monitored daily until asymptotic task performance was achieved.
Surgery
After behavioral performance stabilized, bilateral guide cannulae
targeting the NAc core were chronically implanted as described
previously (Nicola, 2010; Lardeux et al., 2015). Briefly, animals
were anesthetized with isofluorane and placed into a stereotaxic
frame with the head flat. Small holes were drilled bilaterally in
the skull at 1.4mm anterior and ± 1.5mm lateral from Bregma.
A stereotaxic arm was used to precisely place the cannulae into
these holes and then lower them into the brain to a final depth of
6mm from the top of the skull (2mm above the NAc). Cannulae
were held in place with bone screws and dental cement. Two
threaded posts were placed vertically on the skull and embedded
in dental cement. These posts interfaced with screws to a head
stage containing two LEDs, which allowed automated video
tracking during experiments. Animals received the antibiotic
enrofloxacin prior to and 1 day post-surgery. After surgery,
rats were given 1 week to recover before a brief post-surgical
retraining period on the 2CS task began.
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Drugs
Drugs were purchased from Sigma and freshly dissolved in 0.9%
sterile saline on the day they were used. Drug doses per side were:
“D1 agonist low,” 0.1 µg SKF81297; “D1 agonist high,” 0.4 µg
SKF81297; “D1 antagonist,” 1.1 µg Schering 23390; “D2 agonist
low,” 1 µg quinpirole; “D2 agonist high,” 10 µg quinpirole; “D2
antagonist,” 2.2 µg raclopride.
Microinjection Procedure
As previously described (Nicola, 2010; Lardeux et al., 2015), rats
were gently restrained with a towel while 33 ga injectors were
inserted into the guide cannulae such that the injector extended
2mm further ventral from the bottom of the guide, reaching the
center of the NAc core. After 1min, 0.5 µL of drug solution was
injected over 2min with a precision syringe pump. Drugs were
given 1min to diffuse, after which the animals were immediately
placed into the operant chambers. The order of drug injections
was randomized across rats. Injections were performed twice
per week (on Tuesdays and either Thursdays or Fridays), with
an intervening uninjected session run on the day prior to each
injection to ensure that behavior recovered from the previous
injection.
Video Tracking
On test days, the rat’s position was recorded using an overhead
camera (30 frames/s) and automated tracking system (either
Plexon Cineplex or Noldus Ethovision). This system tracked
the x and y positions of red and green LEDs attached to the
rat’s head. As previously described (Nicola, 2010; McGinty et al.,
2013; du Hoffmann and Nicola, 2014; Morrison and Nicola,
2014), to determine the rat’s position in the operant chamber we
calculated a centroid (the center point) between the LEDs for
each video frame. Missing positions up to 10 successive frames
were linearly interpolated; if> 10 successive frames were missing
the data were discarded. For each frame, we then calculated
the SD of the distances of centroid positions within a temporal
window of 200ms. When log transformed, these SD values were
bimodally distributed, with the lower peak representing epochs
of non-movement and the upper peak movement. We then fit
two Gaussian functions to these distributions and the movement
threshold was determined as the point where the upper and lower
distributions overlapped the least. Movement was defined as 8
consecutive frames above this threshold.
Data Analysis
One rat failed to re-attain pre-surgery performance levels
after cannula implantation and thus was not subjected to
microinjections. The cannulae from a second rat became clogged
and consequently some microinjections were not performed.
Thus, data were obtained from 7 microinjections for some
experiments and 6 for others. Behavioral time stamps and raw
video tracking position data were exported and analysis was
performed with custom routines in the R statistical computing
environment (R Core Team, 2013).
In Figures 1B–E, we calculated the cue response ratio by
dividing the number of cues responded to by the number of cues
presented in 15 min or 1 h bins and plotted them as cross-session
FIGURE 1 | D1 and D2 receptor agonists and antagonists, respectively
promote and attenuate cued approach to reward. (A) 2CS+ task
schematic. Time is not to scale. (B,C) Single session average response ratio
(% of cues responded to) in 15min time bins to cues that predict large (B) and
small (C) volumes of 10% sucrose (black line), and the first three (gray) and
fourth (orange) days after the switch to equivalent volumes of 3% sucrose
reward. (D) Symbols show the mean response ratios to cues that predict 250
µl (“Large”) or 150 µl (“Small”) of 3% sucrose reward after injection of saline
(black circles), low (red open squares) and high doses (light red squares) of the
D1 receptor agonist SKF 81927, and of the D1 antagonist SCH 23390 (dark
red triangles), into the NAc core. The bold lines connect the response ratio
data from the first and second hour of the behavioral session. (E) The graph
follows identical conventions to those in (D) for injection of saline (black
circles), low (blue open squares) and high dose D2 receptor agonist quinpirole
(light blue squares) and D2 antagonist raclopride (dark blue triangles) into the
NAc core. Error bars in this and all subsequent figures denote SEM. *p < 0.05
compared to saline. See Table 1 for all statistical results. See Methods Section
Drugs for drug doses.
means. To assess task variables that influence performance in
each drug, we used repeated measures ANOVA with response
ratio as the dependent variable against two factors, time interval
(1 and 2 h) and cue type (large and small). Post-hoc two-tailed
paired t-tests were used within each drug condition to test
whether session time and cue type (large and small) significantly
influenced response ratio. Two-tailedWelch’s t-tests were used to
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compare response ratios for each drug to saline. P values for post-
hoc t-tests were corrected using the Sidak multiple comparisons
correction procedure. The significance threshold for all statistical
tests was set at p < 0.05. The results from all statistical tests can
be found in Table 1.
In Figures 2F,G, cues with no response were first flagged, and
“pauses” were defined as ≥2 successive trials with no response.
The pause length was defined as the time interval between cues
with responses. The cumulative time spent in pauses is plotted
against the sequential pause number (left panels), and the mean
cumulative time spent in pauses through the end of the session
is shown in the bar plots (right panels). One-way ANOVAs with
drug type as a factor were used to assess whether the number of
pauses or the cumulative time spent in pauses differed between
drugs. Post-hoc two-tailed Sidak-corrected Welch’s t-tests were
used to compare both pause number and total time spent in
pauses in each drug and saline.
In Figures 4A,C,F,H, each trial t was coded as eliciting a
response (R+) or failing to elicit a response (R−). We then
calculated the empirical probability of the occurrence of R+ or
R− at t+1. This procedure results in 4 probability measures,
each of which is associated with a unique pattern of response
and no response on the two consecutive trials, t and t+1:
P(R+R+), P(R+R−), P(R−R−), P(R−R+). When these probabilities
are arranged so that each couplet that begins with the same
response type (R+ or R−) is on the same row of a 2 × 2
matrix, each row sums to one; i.e., the matrix is right stochastic.
In Figures 4A,C,F,H, we plotted (separately for each drug) the
mean probabilities for each couplet with the row values of these
matrices on the same axis. For example, P(R+R+), P(R+R−) are
on the vertical axis because each couplet begins with an R+.
Because each row of each matrix sums to one, the matrix values
are all positive, and the rat can freely transition from a responsive
(R+) to non-responsive state (R−), and vice versa, the stochastic
matrix can describe a Markov chain for which a stationary
probability vector pi can be calculated. These probability vectors
are estimates of the probability of finding the rat in the responsive
and non-responsive state at a steady state of the Markov chain
(Figure 3). To calculate the components of pi, we transposed
eachmatrix, found the left eigenvalues of the transposed matrices
and then divided these values by their sum (which ensures
that the components of pi sum to 1). The mean probability
vector for each treatment group is plotted in Figures 4B,D,G,I.
Thus, we have two unique ways of characterizing behavior: by
the stochastic matrix, which graphically shows mean transition
probabilities, and by the vector of stationary probabilities,
which yields an estimate of the probability that the rat is in
either the responsive or non-responsive state. To compare these
probability vectors across drugs and time, we subtracted the
two components of pi, an approach that preserves information
about the relative direction of the pair of probability estimates.
In Figures 4E,J, we plotted the cross-session median and middle
quartiles of these differences within each drug separately for
each session hr. To determine for each drug whether these
probability vectors differed between the first and second hour of
the sessions, we compared their differences with pairedWilcoxon
signed rank tests. Next, we performed non-paired Wilcoxon
signed rank tests (saline vs. drug) within each hr and corrected
the 6 p values (one for each drug vs. saline) with a Sidak
correction.
In Figures 5A,B, cues to which the animal responded were
first isolated. In Figure 5A, the latencies of the animal to begin
movement directed toward the receptacle (left bars) and to reach
the reward receptacle (right bars) were calculated and plotted
as the cross-session mean. In Figure 5B, we calculated, for each
trial, the length of the path (in cm) that the animal took to the
receptacle from its position at cue onset. We then calculated
the ratio of two values: (A) the straight-line distance between
the rat’s position at cue onset and the receptacle, and (B) the
length of the actual path taken to reach the receptacle. These
A:B ratios are termed “path efficiency” values; they range from
0 to 1, with values closer to 1 indicating more efficient (less
circuitous) paths. Path efficiencies were plotted as cross-session
means for each drug type. To assess whether each of these latency
values or the path efficiency measure differed between drugs, we
performed one way ANOVAs with drug as a factor. In Figure 5C,
for each trial with a rewarded receptacle entry we counted the
number of receptacle entries 5 s prior to cue onset and 5 s after
cue onset. These counts were then converted to rates (entries per
s) by summing them over all rewarded trials in the session and
dividing this value by the number of rewarded trials multiplied
by 5 s (the longest possible trial length). The cross-session mean
rates for each drug are shown in the bar plots in Figure 5C.
To compare these two rates, for each drug, we used repeated
measures ANOVA with time interval (pre and post cue intervals)
as an independent variable. To compare receptacle entry rates
between saline and drug within each time interval, we performed
Sidak-corrected Welch’s t-tests. In Figure 5D, we sorted trials
by the preceding inter-trial interval (ITI) length and grouped
these values into 10 s bins. We then calculated response ratios
for trials with ITIs that fell within each bin and calculated the
cross-session mean for each drug. We used ITI bin number
as a factor in a repeated measures ANOVA to assess whether,
in each drug, response probability varied across ITI durations.
In Figure 5E, for each trial we calculated the total distance
traveled (in cm) during the ITI preceding cue onset. Then we
calculated the within-session mean distance traveled in the ITIs
preceding cues to which the animal responded, and similarly for
cues to which the animal did not respond. To assess whether
total distance traveled differed between trials with and without
a subsequent cued response, within each drug we used repeated
measures ANOVA with response type as a factor. Next, we
performed post-hoc Sidak-corrected Welch’s t-tests to compare
average path lengths traveled for each response type (drug vs.
saline).
Histology
Animals were deeply anesthetized with Euthasol and decapitated
with a guillotine. Brains were quickly removed from the skull
and then fixed in formalin. Prior to slicing with a cryostat, brains
were cryoprotected by immersion in 30% sucrose for several days.
Sections (50 µm) were stained for Nissl substance to visualize
cannula and injector tracks. Estimates of injection sites for each
animal are shown in Figure 6.
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TABLE 1 | Statistical results.
Figure Drug (s) Variables Event Test Result
Figures 1D,E Saline hour Response (%) Repeated measures ANOVA F (1, 6) = 46.02, P ≤ 0.001
Figures 1D,E Saline cue type Response (%) Repeated measures ANOVA F (1, 6) = 46.72, P ≤ 0.001
Figures 1D,E Saline hour × cue type Response (%) Repeated measures ANOVA F (1, 6) = 19.87, P = 0.004
Figures 1D,E Saline Large 1 h vs. Large 2 h Response (%) paired t-test t(6) = 6.339, P ≤ 0.001
Figures 1D,E Saline Small 1 h vs. Small 2 h Response (%) paired t-test t(6) = 6.928, P ≤ 0.001
Figures 1D,E Saline Large 1 h vs. Small 1 h Response (%) paired t-test t(6) = 6.312, P ≤ 0.001
Figures 1D,E Saline Large 2 h vs. Small 2 h Response (%) paired t-test t(6) = 1.334, P = 0.231
Figure 1D D1 agonist low dose hour Response (%) Repeated measures ANOVA F (1, 6) = 3.28, P = 0.12
Figure 1D D1 agonist low dose cue type Response (%) Repeated measures ANOVA F (1, 6) = 5.81, P = 0.053
Figure 1D D1 agonist low dose hour × cue type Response (%) Repeated measures ANOVA F (1, 6) = 0.66, P = 0.448
Figure 1D D1 agonist high dose hour Response (%) Repeated measures ANOVA F (1, 5) = 1.98, P = 0.219
Figure 1D D1 agonist high dose cue type Response (%) Repeated measures ANOVA F (1, 5) = 28.27, P = 0.003
Figure 1D D1 agonist high dose hour × cue type Response (%) Repeated measures ANOVA F (1, 5) = 0, P = 0.978
Figure 1D D1 antagonist hour Response (%) Repeated measures ANOVA F (1, 6) = 3.88, P = 0.096
Figure 1D D1 antagonist cue type Response (%) Repeated measures ANOVA F (1, 6) = 5.01, P = 0.066
Figure 1D D1 agonist low dose Large 1 h vs. Large 2 h Response (%) paired t-test t(6) = 1.632, P = 0.154
Figure 1D D1 agonist low dose Small 1 h vs. Small 2 h Response (%) paired t-test t(6) = 2.031, P = 0.089
Figure 1D D1 agonist low dose Large 1 h vs. Small 1 h Response (%) paired t-test t(6) = 2.106, P = 0.08
Figure 1D D1 agonist low dose Large 2 h vs. Small 2 h Response (%) paired t-test t(6) = 1.732, P = 0.134
Figure 1D Saline vs. D1 agonist low dose Large 1 h Response (%) Sidak corrected Welch’s t-test t(12) = 0.231, P = 1
Figure 1D Saline vs. D1 agonist low dose Small 1 h Response (%) Sidak corrected Welch’s t-test t(12) = –0.841, P = 0.834
Figure 1D Saline vs. D1 agonist low dose Large 2 h Response (%) Sidak corrected Welch’s t-test t(12) = –1.776, P = 0.303
Figure 1D Saline vs. D1 agonist low dose Small 2 h Response (%) Sidak corrected Welch’s t-test t(12) = –1.706, P = 0.312
Figure 1D D1 agonist high dose Large 1 h vs. Large 2 h Response (%) paired t-test t(6) = 1.902, P = 0.106
Figure 1D D1 agonist high dose Small 1 h vs. Small 2 h Response (%) paired t-test t(6) = 0.844, P = 0.431
Figure 1D D1 agonist high dose Large 1 h vs. Small 1 h Response (%) paired t-test t(6) = 5.29, P = 0.002
Figure 1D D1 agonist high dose Large 2 h vs. Small 2 h Response (%) paired t-test t(6) = 3.179, P = 0.019
Figure 1D Saline vs. D1 agonist high dose Large 1 h Response (%) Sidak corrected Welch’s t-test t(12) = –3.175, P = 0.024
Figure 1D Saline vs. D1 agonist high dose Small 1 h Response (%) Sidak corrected Welch’s t-test t(12) = –3.54, P = 0.012
Figure 1D Saline vs. D1 agonist high dose Large 2 h Response (%) Sidak corrected Welch’s t-test t(12) = –7.444, P ≤ 0.001
Figure 1D Saline vs. D1 agonist high dose Small 2 h Response (%) Sidak corrected Welch’s t-test t(12) = –6.76, P ≤ 0.001
Figure 1D D1 antagonist Large 1 h vs. Large 2 h Response (%) paired t-test t(6) = 1.991, P = 0.094
Figure 1D D1 antagonist Small 1 h vs. Small 2 h Response (%) paired t-test t(6) = 1.825, P = 0.118
Figure 1D D1 antagonist Large 1 h vs. Small 1 h Response (%) paired t-test t(6) = 1.823, P = 0.118
Figure 1D D1 antagonist Large 2 h vs. Small 2 h Response (%) paired t-test t(6) = 2.749, P = 0.033
Figure 1D Saline vs. D1 antagonist Large 1 h Response (%) Sidak corrected Welch’s t-test t(12) = 4.523, P = 0.005
Figure 1D Saline vs. D1 antagonist Small 1 h Response (%) Sidak corrected Welch’s t-test t(12) = 3.791, P = 0.012
Figure 1D Saline vs. D1 antagonist Large 2 h Response (%) Sidak corrected Welch’s t-test t(12) = 1.41, P = 0.368
Figure 1D Saline vs. D1 antagonist Small 2 h Response (%) Sidak corrected Welch’s t-test t(12) = 2.063, P = 0.248
Figure 1E D1 antagonist hour × cue type Response (%) Repeated measures ANOVA F (1, 6) = 1.35, P = 0.289
Figure 1E D2 agonist low dose hour Response (%) Repeated measures ANOVA F (1, 5) = 6.65, P = 0.05
Figure 1E D2 agonist low dose cue type Response (%) Repeated measures ANOVA F (1, 5) = 15.34, P = 0.011
Figure 1E D2 agonist low dose hour × cue type Response (%) Repeated measures ANOVA F (1, 5) = 0.25, P = 0.64
Figure 1E D2 agonist high dose hour Response (%) Repeated measures ANOVA F (1, 5) = 2.44, P = 0.179
Figure 1E D2 agonist high dose cue type Response (%) Repeated measures ANOVA F (1, 5) = 43.31, P ≤ 0.001
Figure 1E D2 agonist high dose hour × cue type Response (%) Repeated measures ANOVA F (1, 5) = 0, P = 0.991
Figure 1E D2 antagonist hour Response (%) Repeated measures ANOVA F (1, 6) = 1.5, P = 0.266
Figure 1E D2 antagonist cue type Response (%) Repeated measures ANOVA F (1, 6) = 0.13, P = 0.735
Figure 1E D2 antagonist hour × cue type Response (%) Repeated measures ANOVA F (1, 6) = 2.44, P = 0.169
Figure 1E D2 agonist low dose Large 1 h vs. Large 2 h Response (%) paired t-test t(5) = 1.988, P = 0.103
(Continued)
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TABLE 1 | Continued
Figure Drug (s) Variables Event Test Result
Figure 1E D2 agonist low dose Small 1 h vs. Small 2 h Response (%) paired t-test t(5) = 2.641, P = 0.046
Figure 1E D2 agonist low dose Large 1 h vs. Small 1 h Response (%) paired t-test t(5) = 3.224, P = 0.023
Figure 1E D2 agonist low dose Large 2 h vs. Small 2 h Response (%) paired t-test t(5) = 3.173, P = 0.025
Figure 1E Saline vs. D2 agonist low dose Large 1 h Response (%) Sidak corrected Welch’s t-test t(11) = –0.283, P = 1
Figure 1E Saline vs. D2 agonist low dose Small 1 h Response (%) Sidak corrected Welch’s t-test t(11) = –0.764, P = 0.834
Figure 1E Saline vs. D2 agonist low dose Large 2 h Response (%) Sidak corrected Welch’s t-test t(11) = –3.164, P = 0.036
Figure 1E Saline vs. D2 agonist low dose Small 2 h Response (%) Sidak corrected Welch’s t-test t(11) = –1.773, P = 0.312
Figure 1E D2 agonist high dose Large 1 h vs. Large 2 h Response (%) paired t-test t(5) = 1.652, P = 0.159
Figure 1E D2 agonist high dose Small 1 h vs. Small 2 h Response (%) paired t-test t(5) = 1.289, P = 0.254
Figure 1E D2 agonist high dose Large 1 h vs. Small 1 h Response (%) paired t-test t(5) = 3.552, P = 0.016
Figure 1E D2 agonist high dose Large 2 h vs. Small 2 h Response (%) paired t-test t(5) = 3.012, P = 0.03
Figure 1E Saline vs. D2 agonist high dose Large 1 h Response (%) Sidak corrected Welch’s t-test t(11) = –3.766, P = 0.012
Figure 1E Saline vs. D2 agonist high dose Small 1 h Response (%) Sidak corrected Welch’s t-test t(11) = –6.149, P ≤ 0.001
Figure 1E Saline vs. D2 agonist high dose Large 2 h Response (%) Sidak corrected Welch’s t-test t(11) = –5.706, P ≤ 0.001
Figure 1E Saline vs. D2 agonist high dose Small 2 h Response (%) Sidak corrected Welch’s t-test t(11) = –3.797, P = 0.015
Figure 1E D2 antagonist Large 1 h vs. Large 2 h Response (%) paired t-test t(6) = –1.608, P = 0.159
Figure 1E D2 antagonist Small 1 h vs. Small 2 h Response (%) paired t-test t(6) = –0.76, P = 0.476
Figure 1E D2 antagonist Large 1 h vs. Small 1 h Response (%) paired t-test t(6) = –0.718, P = 0.5
Figure 1E D2 antagonist Large 2 h vs. Small 2 h Response (%) paired t-test t(6) = 1.472, P = 0.191
Figure 1E Saline vs. D2 antagonist Large 1 h Response (%) Sidak corrected Welch’s t-test t(12) = 9.966, P ≤ 0.001
Figure 1E Saline vs. D2 antagonist Small 1 h Response (%) Sidak corrected Welch’s t-test t(12) = 6.352, P ≤ 0.001
Figure 1E Saline vs. D2 antagonist Large 2 h Response (%) Sidak corrected Welch’s t-test t(12) = –0.66, P = 0.522
Figure 1E Saline vs. D2 antagonist Small 2 h Response (%) Sidak corrected Welch’s t-test t(12) = –0.5, P = 0.626
Figures 2F,G All injection types Count Pauses in cue responding One-way ANOVA F (6,6) = 5.49, P ≤ 0.001
Figures 2F,G All injection types Cumulative time (s) Pauses in cue responding One-way ANOVA F (6,37) = 10, P ≤ 0.001
Figure 2F Saline vs. D1 agonist low dose Count Pauses in cue responding Sidak corrected Welch’s t-test t(12) = –0.159, P = 0.876
Figure 2F Saline vs. D1 agonist high dose Count Pauses in cue responding Sidak corrected Welch’s t-test t(12) = –3.941, P = 0.012
Figure 2F Saline vs. D1 antagonist Count Pauses in cue responding Sidak corrected Welch’s t-test t(12) = 3.158, P = 0.04
Figure Drug (s) Variables Event Test Result
Figure 2F Saline vs. D1 agonist low dose Cumulative time (s) Pauses in cue responding Sidak corrected Welch’s t-test t(12) = 0.94, P = 0.616
Figure 2F Saline vs. D1 agonist high dose Cumulative time (s) Pauses in cue responding Sidak corrected Welch’s t-test t(12) = 4.498, P = 0.006
Figure 2F Saline vs. D1 antagonist Cumulative time (s) Pauses in cue responding Sidak corrected Welch’s t-test t(12) = –3.89, P = 0.006
Figure 2G Saline vs. D2 agonist low dose Count Pauses in cue responding Sidak corrected Welch’s t-test t(11) = –0.805, P = 0.876
Figure 2G Saline vs. D2 agonist high dose Count Pauses in cue responding Sidak corrected Welch’s t-test t(11) = –1.317, P = 0.642
Figure 2G Saline vs. D2 antagonist Count Pauses in cue responding Sidak corrected Welch’s t-test t(12) = 1.917, P = 0.316
Figure 2G Saline vs. D2 agonist low dose Cumulative time (s) Pauses in cue responding Sidak corrected Welch’s t-test t(11) = 1.069, P = 0.616
Figure 2G Saline vs. D2 agonist high dose Cumulative time (s) Pauses in cue responding Sidak corrected Welch’s t-test t(11) = 4.618, P = 0.006
Figure 2G Saline vs. D2 antagonist Cumulative time (s) Pauses in cue responding Sidak corrected Welch’s t-test t(12) = –4.541, P = 0.006
Figures 4E,J Saline 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P < 0.05
Figure 4E D1 agonist low dose 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P > 0.1
Figure 4E D1 agonist high dose 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P > 0.1
Figure 4E D2 agonist high dose 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P > 0.1
Figure 4E D2 agonist low dose 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P > 0.1
Figure 4E D2 agonist high dose 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P > 0.1
Figure 4E Saline vs. D1 agonist low dose 1 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P > 0.1
Figure 4E Saline vs. D1 agonist low dose 2 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P > 0.1
Figure 4E Saline vs. D1 agonist high dose 1 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P < 0.05
Figure 4E Saline vs. D1 agonist high dose 2 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P < 0.05
Figure 4E Saline vs. D2 agonist low dose 1 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P > 0.1
Figure 4E Saline vs. D2 agonist low dose 2 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P < 0.1
(Continued)
Frontiers in Behavioral Neuroscience | www.frontiersin.org 6 July 2016 | Volume 10 | Article 144
du Hoffmann and Nicola Dopamine Promotes Cued Approach
TABLE 1 | Continued
Figure Drug (s) Variables Event Test Result
Figure 4E Saline vs. D2 agonist high dose 1 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P < 0.05
Figure 4E Saline vs. D2 agonist high dose 2 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P < 0.05
Figure 4J D1 antagonist 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P > 0.1
Figure 4J D2 antagonist 1 vs. 2 h Component 1-Component 2 Paired Wilcoxon signed-rank test P > 0.1
Figure 4J Saline vs. D1 antagonist 1 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P < 0.05
Figure 4J Saline vs. D1 antagonist 2 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P > 0.1
Figure 4J Saline vs. D2 antagonist 1 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P < 0.05
Figure 4J Saline vs. D2 antagonist 2 h Component 1-Component 2 Non-Paired Wilcoxon signed-rank test P > 0.1
Figure 5A All injection types Onset latency (s) Cued Movement One-way ANOVA F (4,37) = 1.06, P = 0.395
Figure 5A All injection types Latency (s) Receptacle entry One-way ANOVA F (4,27) = 0.43, P = 0.784
Figure 5B All injection types Efficiency Cued Movement One-way ANOVA F4,27 = 1.19, P = 0.339
Figure 5C saline Rate in 1 and 2 h Receptacle entry Repeated Measures ANOVA F (1, 6) = 3.46, P = 0.112
Figure 5C D1 agonist low dose Rate in 1 and 2 h Receptacle entry Repeated Measures ANOVA F (1, 6) = 4.76, P = 0.072
Figure 5C D1 agonist high dose Rate in 1 and 2 h Receptacle entry Repeated Measures ANOVA F (1, 6) = 4.94, P = 0.068
Figure 5C D2 agonist low dose Rate in 1 and 2 h Receptacle entry Repeated Measures ANOVA F (1, 5) = 5.05, P = 0.075
Figure 5C D2 agonist high dose Rate in 1 and 2 h Receptacle entry Repeated Measures ANOVA F (1, 5) = 2.43, P = 0.18
Figure 5C Saline vs. D1 agonist low dose Rate (Hz) pre-cue Receptacle entry Sidak corrected Welch’s t-test t(12) = 0.068, P = 1
Figure 5C Saline vs. D1 agonist low dose Rate (Hz) post-cue Receptacle entry Sidak corrected Welch’s t-test t(12) = –0.635, P = 1
Figure 5C Saline vs. D1 agonist high dose Rate (Hz) pre-cue Receptacle entry Sidak corrected Welch’s t-test t(12) = –0.875, P = 1
Figure 5C Saline vs. D1 agonist high dose Rate (Hz) post-cue Receptacle entry Sidak corrected Welch’s t-test t(12) = –0.681, P = 1
Figure 5C Saline vs. D2 agonist low dose Rate (Hz) pre-cue Receptacle entry Sidak corrected Welch’s t-test t(11) = 0.494, P = 1
Figure 5C Saline vs. D2 agonist low dose Rate (Hz) post-cue Receptacle entry Sidak corrected Welch’s t-test t(11) = –0.46, P = 1
Figure 5C Saline vs. D2 agonist high dose Rate (Hz) pre-cue Receptacle entry Sidak corrected Welch’s t-test t(11) = –1.039, P = 1
Figure 5C Saline vs. D2 agonist high dose Rate (Hz) post-cue Receptacle entry Sidak corrected Welch’s t-test t(11) = –0.599, P = 1
Figure 5D saline ITI length (10 s bins) Response (%) Repeated measures ANOVA F (5, 5) = 2.04, P = 0.107
Figure 5D D1 agonist high dose ITI length (10 s bins) Response (%) Repeated measures ANOVA F (5,5) = 0.71, P = 0.621
Figure 5D D2 agonist high dose ITI length (10 s bins) Response (%) Repeated measures ANOVA F (5,5) = 1.24, P = 0.318
Figure 5E Saline Path length (cm) Response type Repeated measures ANOVA F (1, 6) = 21.13, P = 0.004
Figure 5E D1 agonist low dose Path length (cm) Response type Repeated measures ANOVA F (1, 6) = 13.51, P = 0.01
Figure 5E D1 agonist high dose Path length (cm) Response type Repeated measures ANOVA F (1, 6) = 1.91, P = 0.216
Figure 5E D2 agonist low dose Path length (cm) Response type Repeated measures ANOVA F (1, 5) = 51.96, P ≤ 0.001
Figure 5E D2 agonist high dose Path length (cm) Response type Repeated measures ANOVA F (1, 5) = 6.69, P = 0.049
Figure 5E Saline vs. D1 agonist low dose Path length (cm) Trials with a response Sidak corrected Welch’s t-test t(12) = 0.995, P = 0.678
Figure 5E Saline vs. D1 agonist low dose Path length (cm) Trials with no response Sidak corrected Welch’s t-test t(12) = –0.01, P = 1
Figure 5E Saline vs. D1 agonist high dose Path length (cm) Trials with a response Sidak corrected Welch’s t-test t(12) = –5.123, P ≤ 0.001
Figure 5E Saline vs. D1 agonist high dose Path length (cm) Trials with no response Sidak corrected Welch’s t-test t(12) = –4.743, P ≤ 0.001
Figure 5E Saline vs. D2 agonist low dose Path length (cm) Trials with a response Sidak corrected Welch’s t-test t(11) = –0.826, P = 0.678
Figure 5E Saline vs. D2 agonist low dose Path length (cm) Trials with no response Sidak corrected Welch’s t-test t(11) = –0.049, P = 1
Figure 5E Saline vs. D2 agonist high dose Path length (cm) Trials with a response Sidak corrected Welch’s t-test t(11) = –2.558, P = 0.081
Each row describes one statistical comparison using the data in the graph indicated by “Figure.” “Drugs” describes the drug condition(s) being compared (an entry of an individual drug
means that the comparison is made only with data obtained after injection of that drug); “Variables” and “Event” together describe the measures being compared; “Test” names the
statistical test used, and “Result” provides the results of the test.
RESULTS
Response Probability
We trained 8 rats to respond to distinct auditory cues that
predicted either a small or large sucrose reward (Figure 1A).
Even though the animals were not food-restricted, they
responded to nearly every cue predictive of 10% liquid sucrose
(Figures 1B,C, black lines) while not substantially discriminating
between large (Figure 1B) and small (Figure 1C) reward
availability. In contrast, from the first day that sucrose reward
concentration was reduced from 10% to 3%, a pronounced
run-down of cued responses was observed across the 2 h of
testing (Figures 1B,C, gray lines). There are at least two possible
explanations for this effect. First, it could be due to a state of
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satiety as animals accrue nutrient with successive cue responses.
However, this is unlikely because nutrient accrues faster with
10% than 3% sucrose rewards of the same volume, yet the run-
down was far more pronounced with 3% sucrose. The second
possibility, which we favor, is that whereas 10% sucrose is
sufficiently reinforcing to maintain responding throughout the
session, equivalent volumes of 3% sucrose are not. Whatever its
cause, the run-down effect allowed us to ask whether activation
of dopamine receptors using exogenous agonists increases the
response ratio. This question cannot be answered using 10%
sucrose rewards or in food-restricted animals because baseline
responding is close to 100% in those conditions and thus cannot
be increased.
By the time performance stabilized, 4 days after switching to
3% sucrose rewards, a difference in responding to large and small
reward cues was evident toward the beginning of the session
(compare Figure 1B with Figure 1C); this difference dwindled
as the session progressed and responding to both cue types
declined. This significant difference between large and small cue
responding is also evident in the average response ratio over the
first hour of the session after saline (vehicle control) injections
in the NAc: subjects responded to 54 ± 5% of large reward-
associated cues and to 33 ± 3% of small reward-associated cues
(Figures 1D,E, left black circles). The probability of responding
to both cues was lower in the second hour; moreover, the
response ratio for the large and small cues was statistically
indistinguishable during this period (Figures 1D,E, right black
circles; see Table 1 for statistical results). Therefore, animals
responded more to cues that predict large than small rewards
only in the first half of the session.
To examine the temporal pattern of responding in greater
detail, we constructed raster plots that show the time of each
cue presentation and whether the animal responded (top raster,
Figure 2A) or not (bottom raster). As shown in an example
session prior to which saline had been injected, both responses
and failures to respond typically occurred in clusters of several
successive cues (Figure 2A). This suggests that there are two
states that dictate response probability: responsive and non-
responsive. Furthermore, as the session progressed, the reduction
in response probability was due to longer periods of time
spent in the non-responsive state (Figure 2A, top raster). To
quantify the changing duration of the non-responsive states, we
plotted, for each session, the cumulative time spent in the paused
(non-responsive) state against the sequential pause number.
In essentially all saline injection sessions, these lines became
steeper toward the end of the session, indicating that individual
non-responsive states became longer as the sessions progressed
(Figures 2F,G, black lines).
To assess the contribution of NAc core dopamine to
the decision to respond to reward-predictive cues, we
pharmacologically increased or decreased D1 or D2 dopamine
receptor signaling by microinjecting the D1 receptor agonist
SKF 81297 or antagonist SCH 23390, or the D2 receptor
agonist quinpirole or antagonist raclopride. We found that
both D1 and D2 agonists significantly increased responding
to cues (Figure 1D, light red squares; Figure 1E, light blue
squares); in particular, the low dose of each agonist increased
responding only in the second hour, whereas the high doses
increased responding across the entire session (Figure 1D,
light open red squares; Figure 1E, light open blue squares).
Generally, responding to large and small reward cues was
increased to roughly equivalent degrees, and this was the
case for both D1 and D2 receptor agonists (Figures 1D,E and
Table 1).
These increases in response ratio were accompanied by a
different pattern of responding compared with saline-treated
animals (Figures 2B,C). In contrast to the control condition,
where the time spent in the non-responsive state increased
as the session progressed, the responses of agonist-treated
animals was comparatively sustained for the entire session, with
brief but relatively frequent transitions to the non-responsive
state (Figure 2F, D1 agonist, light red lines; Figure 2G, D2
agonist, light blue lines). Both agonists significantly reduced the
cumulative time spent in the non-responsive pause state and
largely prevented the steep increase in the cumulative time spent
in pauses that occurred in the second hour of the session in
saline-treated animals.
Antagonists to both D1 and D2 receptors had the opposite
effect of the agonists. The antagonists strongly reduced
responding to cues in the first half of the session, while
leaving responding in the second half unchanged (likely due to
a floor effect) (Figure 1D), dark red triangles; (Figure 1E,
dark blue triangles). Both antagonists also significantly
prolonged the cumulative time spent in the non-responsive
state (Figures 2D,E,F,G).
Transition Probabilities
The increase in cue responses caused by the D1 and D2
agonists, as well as the greater time spent in the responsive
than the non-responsive state, could be explained either by an
increased probability of transitioning from the non-responsive
to the responsive state, or conversely, a decreased probability of
transitioning from the responsive to the non-responsive state (or
both). To determine which of these was the case we implemented
a simple two state Markov model (Figure 3) by calculating
empirical transition probability matrices for the 4 possible pairs
of successive events: two successive cued responses (R+R+), a
response to a cue followed by a non-response to the next cue
(R+R−), a non-response followed by a response (R−R+), and
a non-response followed by a non-response (R−R−). Note that
R+R+ and R−R−correspond to remaining in the responsive
and non-responsive states, respectively; and that R+R− and
R−R+ correspond to transitioning from one state to another.
The probability of each of these pairs of outcomes was computed
by dividing the number of times the pair occurred in a given time
window (e.g., the first hour of the session) by the number of times
the first member of the pair occurred (e.g., P(R+R−) = N(R+R−)
/ N(R+); see Methods section Data analysis). Note that the
probability of transitioning out of a state is therefore 1 minus the
probability of remaining in a state (e.g., P(R+R−) = 1 – P(R+R+)).
Thus, in Figures 4A,C,F,H, the data on the vertical axis of the left
graphs show the average (across rats) probability of maintaining
or transitioning out of the responsive state, whereas the data
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FIGURE 2 | D1 and D2 receptor agonists decrease time spent in the non-responsive state. (A–E) Rasters show five example sessions, one for each drug
(high doses only). Each line represents the time at which a cue predicting large (black) or small reward (orange) was presented. The top raster of each pair indicates
cues that the animal responded to by entering the receptacle. The bottom raster indicates cues that the animal did not respond to. Note that the length of the
non-responsive state is longer toward the end of the session in the control condition (A), but the non-responsive state is very short or absent in the D1 agonist (B) and
D2 agonist (C). (F) The left graph plots cumulative time spent in the non-responsive state against the number of transitions from responsive to non-responsive. Thus,
steeper lines indicate long pauses (non-responses to contiguous sequences of cues) interrupted with few responses and shallower lines represent short pauses with
frequent responses. Each line is the data from an individual rat. The bar plots on the right show the mean cumulative time spent in a non-responsive state over the
entire session for each treatment group. Color conventions are identical to those in Figure 1D. (G) The graphs follow identical conventions to those in (F), but here for
the D2 agonist and antagonist treatments. Color conventions are the same as those in Figure 1E. *p < 0.05.
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FIGURE 3 | Schematic of a two-state Markov model. On a given trial, a rat can either stay in the responsive (left circle and looping arrow) or non-responsive state
(right circle and looping arrow) or transition to the other state (arrows between the circles). Each of these events occurs with a probability that is calculated by
classifying all trials as those in which the animal responded (R+) and did not respond (R−), and then classifying the next trial in the same way. This procedure results in
4 possible categories for any consecutive pair of trials: R+,R+; R+,R−; R−,R−; and R−,R+. The probability of the second trial outcome given the first is determined
with the equation P(Response type 1, Response type 2) = N(Response type 1, Response type 2) / N(Response type 1), where N is the number of trials. The 4 categories that
describe the possible behaviors in any pair of trials form a stochastic matrix. We resolved this matrix into steady state probability vectors, which yield an estimate of
the probability of finding each subject in either the responsive or non-responsive state at a steady state of the Markov chain.
on the horizontal axis shows the probability of maintaining or
transitioning out of the non-responsive state.
In the first hour of behavioral testing, saline-treated rats
tended to cluster their cue responding: if they responded to
one cue, the probability of a response to the next cue was
greater than that of a non-response (P(R+R+) > P(R+R−);
Figure 4A, vertical axis); conversely, if they did not respond to
a cue, the probability of a non-response to the next cue was
greater than that of a response (P(R−R−) > P(R−R+); Figure 4A,
horizontal axis). Treatment with either the D1 or D2 agonist
did not strongly change the probability of remaining in the
responsive state (R+R+) [or, equivalently, the probability of
transitioning to the non-responsive state (R+R−)] compared
to saline injections (Figure 4A, vertical axis). However, agonist-
treated animals transitioned significantly more frequently from
the non-responsive to the responsive state (and, equivalently,
remained in the non-responsive state less frequently; Figure 4A,
horizontal axis).
In the second hour of the session, saline-treated rats showed
a marked decrease in the probability that they would transition
from the non-responsive to the responsive state compared to the
first hour (Figure 4C vs. Figure 4A, horizontal axis). Moreover,
they were more likely to transition from the responsive to
the non-responsive state in the second hour than the first
(Figure 4C vs. Figure 4A, vertical axis). Therefore, as the session
progressed, under control conditions the decline in responding
(Figures 1B,D) was due to both longer non-responsive states
and shorter responsive states. Treatment with either D1 or D2
agonists shifted the response probabilities in the second hour
along both axes (Figure 4C). Therefore, whereas in the first
hour the agonists increased the likelihood of transitioning out of
the non-responsive state without affecting transitions out of the
responsive state, in the second hour, the agonists both increased
transitions out of the non-responsive state and decreased
transitions out of the responsive state—meaning that the agonists
both increased the length of responsive states and decreased
the length of non-responsive states. Notably, these effects of
the agonists caused the second-hour transition probabilities to
resemble those in the first hour in the control condition. That
is, the agonists prevented the decline in responding in the
second hour by preventing the normal shift toward transition
probabilities that favored the non-responsive state.
Both the D1 and the D2 antagonist shifted responding in
the first hour along both axes, indicating that they encouraged
transitions toward the non-responsive state as well as prevented
transitions to the responsive state (Figure 4F). Intriguingly, in
the second hour, the transition probabilities in antagonist and
in saline were nearly identical (Figure 4H), and the transition
probabilities in antagonist-treated animals were not significantly
different in the first and second hour (Figure 4F vs. Figure 4H).
These results indicate that D1 and D2 antagonists induce, in
the first hour, a set of transition probabilities that is nearly
identical to that which normally occurs in the second half of the
session in control conditions, corresponding to long stretches of
non-responsiveness to cues.
To statistically compare these transition probabilities in drug
and saline, we resolved each matrix into probability vectors; i.e.,
we estimated, from the transitionmatrices, the probability of each
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FIGURE 4 | D1 and D2 receptor agonists promote transistions from the non-responsive to responsive state. (A,C,F,H). These graphs show the associated
transition probabilities for all 4 possible response/no response pairs, calculated with the equation given in the legend to Figure 3. (A) The dots represent the transition
probabilities in the first hour of behavioral testing for saline (black), high dose D1 agonist (red) and high dose D2 agonist (blue) treated rats. Note that in this first hour
there is a very high probability of responding to a cue if the rat responded to the previous cue; this is indicative of response clustering. (B) The dots represent the
cross-session mean of the components of the probability vectors calculated from the transition matrices that compose the mean probabilities in (A). The two
components give a steady state estimate of the probability of the rats being in the high (“High,” left dots) and low (“Low” right dots) responsive state, respectively. D1
agonist data is almost completely obscured by the D2 agonist data. (C,D) This data comes from the same sessions as in (A,B), but the data is taken from the second
hour of testing. (E) Dot plots show the median and middle quartiles of the differences between the two components of the probability vectors that are shown in (B)
(left set of dot plots) and (D) (right dot plots). Filled symbols represent saline and high agonist doses. Open symbols represent low agonist doses (corresponding data
in (A–D) are not shown for low doses). (F–J) Same plotting conventions as in (A–E), but these figures show data from the first (F,G) and second hour (H,I) after saline
(black), D1 antagonist (dark red) and D2 antagonist (dark blue) injections. *p < 0.05.
rat in each condition being in a responsive and non-responsive
state at the steady state of a Markov chain (see Methods, section
Data analysis, and Figure 3). In Figures 4B,D, it is evident that
in the control (saline) condition, the probability distributions for
the responsive and non-responsive state strongly shift toward
the non-responsive state in the second hour. In contrast, these
probabilities are relatively stable in both agonists across the
entire session. In antagonist (Figures 4G,I), the distribution
of the probabilities of each state are strongly shifted toward
the non-responsive state in both hr and these probabilities
are nearly identical to those in the second hour in saline
treated animals. In Figures 4E,J we subtracted, for each session
hr and each drug, the components of the probability vectors
shown in Figures 4B,D,G,I. Thus, values above and below
zero indicate a greater probability of being in the responsive
and non-responsive state, respectively. During the first hour
in saline, there was a near equal probability of being in the
responsive and non-responsive states. In the second hour, this
distribution of state probabilities significantly shifted toward
the non-responsive state (Figure 4E, left black dots vs. right
black dots). In the high dose of either agonist, there was a
significant increase in the probability of being in the responsive
state in the first hour compared to saline (Figure 4E, left dots)
and this was maintained in the second hour of the session
(Figure 4E, right dots). Thus, constitutive activation of dopamine
receptors is sufficient to promote and maintain the responsive
state under conditions of normative satiety. The antagonists had
the opposite effect; they strongly and significantly shifted the state
probability distributions toward the non-responsive state in both
the first and second session hour. Furthermore, there was no
difference statistically between the state probability distributions
in antagonist and in saline during the second hour of the
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FIGURE 5 | The dopamine agonists increase locomotion, but increased cue responding is not attributable to increased locomotion. (A) The left group of
bars shows the effects of injection of saline, D1 and D2 agonists on the mean latency to initiate movement after cue onset, and the right group shows the mean
latency to reach the receptacle. Color conventions are the same as in Figures 1D,E. (B) Path efficiency (a measure of directness of approach to the receptacle) was
not affected by either agonist or saline. (C) The mean rate of receptacle entry 5 s before (left group of bars) and during cue presentation (right group) for trials with a
behavioral response. (D) The mean response ratio (%) for different ITI lengths (bin width = 10 s) after saline (black), D1 agonist (light red) and D2 agonist (light blue)
injection. The probability of a cued response was not significantly correlated with ITI length in any of the treatment groups. (E) The bars show the mean rate of
locomotion during ITIs when rats respond (left group of bars) and do not respond (right group) to the subsequent cue. *p < 0.05, +p < 0.1.
session. Thus, blocking dopamine receptor activation induces a
non-responsive state with the same efficacy as task experience
over time in the control condition. Furthermore, activation of
these same receptors powerfully promotes a transition to the
responsive state to cues that predict food reward even in the
absence of caloric need.
Cued and Uncued Locomotion
It is possible that the agonist effects resulted from greater
non-directed receptacle entries due to a non-specific increase
in locomotion rather than an increase in receptacle-directed
approach responses. To compare these hypotheses, we used video
tracking data to examine post-cue movement parameters on
trials where the animal responded to the cue. There was no
statistically significant difference between control and agonist
treated sessions in the latency to initiate locomotion after
cue onset (Figure 5A, left bars) or the latency to reach the
receptacle (Figure 5A, right bars). In addition, the path efficiency
of the cued movement (the ratio of the length of a straight
line between the animal and the receptacle to the length of
the path the animal actually followed) was not changed by
agonist treatments (Figure 5B). Because non-directed, random
movements resulting in receptacle entry would be expected to
be less direct (and therefore less efficient) and/or to occur at
longer latency, these observations suggest that the agonist-treated
animals made directed movements toward the reward receptacle
after cue onset in a manner similar to their cued approach
movements in saline.
We next assessed whether agonist-induced increases in cued
entries could have been due to a non-specific increase. Examining
only trials with a response, we compared the rate of receptacle
entries in the 5 s prior to cue onset to the rate of entry in the
5 s after cue onset. The agonists did not significantly increase the
average rate of either spontaneous or cued entries (Figure 5C)
which suggests that receptacle entry remains under cue control
in agonist. Together, the results in Figures 5A–C demonstrate
that the increase in probability of cued approach caused by
the agonists is not attributable to non-specific factors such as
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FIGURE 6 | Histological reconstruction of injection sites. Figure depicts
two coronal sections of rat brain that encompass the majority of the
anterior-posterior extent of the NAc (0.8–2.8mm anterior from Bregma). Black
dots represent estimates of the location of microinjections for each animal.
an increase in non-directed locomotion or the rate of uncued
receptacle entries.
Locomotion during ITIs
Although the agonist-induced increase in cued responding was
not attributable to an increase in non-directed locomotion, this
conclusion does not preclude the possibility that the agonists
nevertheless induced a concomitant increase in locomotion not
directed toward the receptacle. To quantify locomotion during
the ITI, we first asked whether the probability of a cue response
varied as a function of ITI length. As shown in Figure 5D,
response ratio (collapsed across large and small cues) was fairly
constant across the entire range of ITI lengths in both agonist
and saline. Next, we calculated average distance traveled per
s of the ITI for each of the treatment groups, and compared
this rate of locomotion across trials where rats responded
and did not respond to the subsequent cue. Intriguingly, in
the control (saline) condition, there was significantly more
locomotion during ITIs followed by a cued receptacle approach
(Figure 5E, right black bar) than when the animals failed to make
a subsequent cued receptacle approach (Figure 5E, left black bar).
These results suggest that uncued locomotion occurs with greater
frequency when the animal is in the responsive state.
To determine whether this process involves dopamine
receptor activation in the NAc, we assessed the effects of the
dopamine agonists on locomotion during the ITI. The D1 agonist
significantly increased locomotion during ITIs both with and
without a subsequent response; similarly, the D2 agonist caused
either a significant increase (no-response trials) or a trend to
an increase (response trials) (Figure 5E). Thus, the dopamine
agonists caused an overall increase in locomotion during the ITIs.
In the presence of agonists, this locomotion occurred at similarly
high levels whether or not the animal subsequently responded,
suggesting that ITI locomotion is more sensitive to dopamine
receptor activation than cue responding. In sum, the results
shown in Figure 5 suggest that, via a mechanism within the
NAc, dopamine receptor activation biases animals both toward
higher probability of responding to cues and higher rates of
spontaneous locomotion, and that even though dopamine has
both of these effects, the higher response probability driven
by dopamine is not a spurious consequence of higher rates of
spontaneous locomotion.
DISCUSSION
NAc Dopamine Is Necessary and Sufficient
for Cued Taxic Approach
Cue-elicited approach is strongly dependent on the mesolimbic
dopamine projection from the VTA to the NAc only in very
specific circumstances: those in which responding involves
“flexible approach” (Nicola, 2010) [also called “taxic” (Petrosini
et al., 1996) or “guidance” (O’keefe and Nadel, 1978) approach;
the term “taxic approach” will be used here]. Taxic approach
refers to locomotion that is directed toward a visible object
from starting locations that vary across approach occasions.
Importantly, taxic approach requires the brain to compute a
novel movement path for each approach event [unlike “praxic,”
“orientation,” or “inflexible” approach, which occurs when the
starting and ending locations are constant across approach events
(O’keefe and Nadel, 1978; Petrosini et al., 1996; Nicola, 2010)].
The present study extends the conclusion that NAc dopamine
is required for taxic approach in four ways. First, whereas the
dependence of taxic approach on mesolimbic dopamine was
first established using a discriminative stimulus (DS) task that
required the animal to approach an operandum (lever or nose
poke) to obtain sucrose reward delivered into a nearby receptacle
(Yun et al., 2004a,b; Ambroggi et al., 2008; Nicola, 2010), in
the present task, animals had simply to approach the reward
receptacle itself. As in the DS task, cues were presented at long
and variable intervals, resulting in diverse starting locations at
cue onset due to the animal’s movement about the chamber
during the intertrial interval (not shown)—conditions under
which approach behavior is necessarily taxic. Our observation
that D1 and D2 dopamine receptor antagonist injection into the
NAc core reduced the proportion of cues to which the animal
responded parallels earlier observations with the DS task (Yun
et al., 2004a,b; Ambroggi et al., 2008; Nicola, 2010). Similar to
earlier findings with a progressive delay task (Wakabayashi et al.,
2004), our results confirm, in a much simpler task, that inclusion
of an explicit operant contingency at a location that differs from
the reward delivery site is not a critical task feature that renders
taxic approach behavior dependent on NAc dopamine.
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Second, whereas earlier studies were conducted in food-
restricted animals, the present work demonstrates that taxic
approach is impaired byNAc dopamine antagonist injection even
in animals given ad libitum access to chow. The dependence
of taxic approach on mesolimbic dopamine is therefore not
a function of nutrient deficit or the subject’s state of hunger.
Indeed, the present results support a role for mesolimbic
dopamine in promoting cue-elicited approach to high-calorie
food even in the absence of a homeostatic need for calories,
supporting the hypothesis that this circuitry contributes to
overeating and obesity (Berridge et al., 2010; Kenny, 2011; Stice
et al., 2013; Meye and Adan, 2014).
Third, whereas previous studies used dopamine antagonists to
show that NAc dopamine is necessary for cued taxic approach,
in the present work we demonstrate that increasing NAc D1 or
D2 dopamine receptor activation by injection of agonists of these
receptors is sufficient to increase the probability that a cue will
elicit taxic approach. This experiment was not possible in most
previous studies because food-restricted rats respond to close to
100% of cues that reliably predict nutrient, imposing a ceiling on
potential agonist effects. However, when sucrose prediction was
made less reliable in a “probabilistic stimulus” (PS) task in which
the PS predicted 10% sucrose reward on only 15% of trials, the
response probability was lower, and pharmacological blockade
of dopamine reuptake increased this probability (Nicola et al.,
2005). In the present study, rats were fed chow ad libitum and
the reward for cue responding was 3% instead of 10% sucrose.
Under these conditions, even though the cues reliably predicted
reward, animals responded to a smaller fraction of cues than
under food-restricted or 10% sucrose conditions, eliminating the
ceiling effect and allowing us to assess the effects of agonists on
cued taxic approach. Consistent with the results from the PS task,
dopamine agonist injection in the NAc core produced a robust
increase in cue responding. The present results therefore establish
that NAc core dopamine receptor activation is both necessary
and sufficient to promote cued taxic approach, supporting our
previous conclusion that mesolimbic dopamine is part of the
causal mechanism for taxic approach initiation (du Hoffmann
and Nicola, 2014).
Fourth, our observation that D1 and D2 agonists have very
similar effects that are the opposite of the effects of D1 and D2
antagonists has important implications for conclusions about
the specificity of the drugs’ effects. In most previous studies,
microinjected D1 and D2 antagonists had very similar behavioral
(Hiroi and White, 1991; Ozer et al., 1997; Koch et al., 2000; Yun
et al., 2004b; Eiler et al., 2006; Pezze et al., 2007; Lex and Hauber,
2008; Liao, 2008; Nicola, 2010; Shin et al., 2010; Haghparast
et al., 2012; Steinberg et al., 2014) and electrophysiological (du
Hoffmann and Nicola, 2014) effects. Because the concentration
of injected antagonists required to observe effects is much
higher than the binding constants of these drugs for their target
receptors, the similarity of D1 and D2 antagonist effects calls into
question their specificity: it is possible that the drugs either bind
to the same dopamine receptor, or to a third receptor class that is
not a dopamine receptor at all. In the former case, activating one
of the receptors should produce no behavioral effect; in the latter
case, activating neither receptor should produce a behavioral
effect. However, we find that D1 and D2 agonists both produce
behavioral effects, and that their effects are identical to each other
and precisely opposite to those of the antagonists. It would be
remarkable if 4 different drugs all acted at the same off-target
receptor. Therefore, the more likely scenario is that all of the
drugs act specifically at their target receptors.
Effects of Dopamine Agonists Are Not Due
to a Generalized Increase in Locomotion
A potential complication with the interpretation that the
dopamine agonists promoted cue responding is that the effect
could have been due to a generalized increase in locomotion,
resulting in spurious receptacle entries that would have occurred
whether or not a cue had been presented. Indeed, in the
control condition, video tracking data obtained during the
session revealed that locomotion rate during the intertial
interval was correlated on a trial-by-trial basis with receptacle
entry probability during the subsequent cue presentation.
Furthermore, the agonists increased both locomotion during the
inter-trial intervals and cue response probability. One way to rule
out a generalized motor effect is to use a non-reward predictive
stimulus (NS) to show that responding to NS presentation is not
increased by the agonists.We did not include anNS in our design.
We hypothesize that had we done so, we would have observed
an increase in locomotion during the NS (as occurred during
the intertrial interval) but not an increase in receptacle entries.
This hypothesis is based on several observations indicating that
the increased entry probability after cue presentation was not a
result of increased generalized locomotion. First, the increase in
locomotion during the inter-trial interval caused by the agonists
was decoupled from the increase in cue responding, occurring
even during intervals that were followed by a non-response
to the cue (Figure 5E). Second, the probability of an uncued
receptacle entry during the ITI was not increased by the agonists
(Figure 5C). Finally, compared with directed entries, entries
resulting from a generalized increase in locomotion would be
expected to occur at longer latency after cue onset, and the animal
would be expected to follow a more circuitous path from its
location at cue onset to the receptacle; however, the agonists
neither increased cue-entry latencies (Figure 5A) nor decreased
movement path efficiency (Figure 5B). Together, these results
indicate that the increase in cued receptacle entries caused by the
agonists is not due to the concomitant increase in locomotion.
A more likely explanation is that some spontaneous locomotor
events were taxic approaches toward objects within the chamber,
and the probability of such approaches was increased by the
agonists just as the probability of taxic approach in response to
our explicitly-presented cues was increased.
Lack of a Pronounced Difference in
Responding to Cues Predicting Large and
Small Reward
Another difference between the current task and our previous
studies using DS and PS tasks is that we presented two reward-
predictive cues, which predicted large and small volumes
of sucrose, rather than one reward-predictive cue and one
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non-reward-predictive stimulus (NS). We included dual
reward-predictive cues in the task design in order to assess
whether manipulations of NAc dopamine receptors differentially
influence behavior triggered by cues predictive of different
reward magnitudes. However, we could not conduct such an
analysis because the animals did not robustly differentiate
between the two cues. When the reward was 10% sucrose, there
were no significant differences in response ratio between large-
and small-reward predictive cues; and when the reward was 3%
sucrose, a small (∼20%) difference was observed only in the first
hour of the session (Figure 1). These observations contrast with
typical behavior in the DS task using exactly the same auditory
stimuli, in which animals respond to >80% of DS presentations
and <10% of NS presentations (Nicola, 2010). More recently,
we found that in a task similar to the present one, using the
same two auditory stimuli but with one cue predictive of reward
contingent on receptacle entry and one NS, responding to the
NS was quite high (>20%; not shown). This high responding
(compared to the low NS response ratio in DS tasks with an
explicit operant requirement) is likely due to some degree of
generalization between the predictive and non-predictive cues,
as well as to the lack of an operant response contingency. The
absence of such a contingency means that cue responding is
less difficult and requires less effort than cue responding in the
DS task, potentially explaining the difference in NS response
probability. If >20% response ratios for a NS are common, then
they should be even higher when the cue predicts a small amount
of reward, precisely as observed in the present study.
Decline in Responding over Time May Be
an Extinction-Like Effect
A striking feature of the behavior observed in our ad libitum
chow-fed animals was a decline in cue response probability
over the 2 h session, which was far more pronounced when
the reward was 3% sucrose than when it was 10% sucrose.
Rats given free access to sucrose show a similar decline in lick
rate from the beginning of the session, which is attributable to
satiation: post-ingestive nutrient detection mechanisms signal
to the brain, resulting in reduced consumption (Smith, 2001).
However, satiation is unlikely to account for the decline in cue
responding observed here because the greater nutrient intake
when 10% sucrose was the reward would be expected to produce
a more rapid decline in responding than when 3% sucrose was
delivered, yet the opposite occurred (Figure 1). Another possible
explanation is that the decline is an extinction-like effect that is
due to delivery of reinforcers that are of insufficient magnitude to
maintain responding to the cues on subsequent trials. Although
we have no direct evidence that this is the case, simply ceasing
to deliver sucrose also results in a decline in responding (not
shown). Although this true extinction effect is more rapid than
that observed here, the slower time course of extinction in the
present case would be expected because a small amount of
sucrose was delivered. Moreover, when a higher concentration
of sucrose (10%) was delivered, almost no decline was observed,
consistent with the idea that 3% sucrose reinforcers were of
insufficient magnitude to maintain responding.
That 3% sucrose is less reinforcing than 10% is hardly
surprising, given not only that 3% sucrose is less preferred over
water than 10% (Sclafani, 1987), but also that 10% sucrose is likely
to more strongly activate post-ingestive processes that detect
nutrient intake, which can contribute to reinforcement even in
the absence of taste (de Araujo et al., 2012; Sclafani and Ackroff,
2012; Sclafani, 2013; de Araujo, 2016). These processes promote
dopamine signaling and in fact appear to be responsible for the
ability of nutritive sucrose reinforcers to sustain progressive ratio
task performance to a far greater extent than sweet non-nutritive
reinforcers (Beeler et al., 2012). Indeed, cues predictive of sucrose
elicit more dopamine release in the NAc than cues predictive
of non-nutritive sweetner (McCutcheon et al., 2012) and, under
some conditions, sucrose itself elicits more dopamine release
than sweetner (Beeler et al., 2012). These results suggest that an
attenuated dopamine signal during 3% sucrose sessions (vs. 10%)
could be responsible for the extinction-like decline in responding
when the lower sucrose concentration was used.
Consistent with this hypothesis, activation and inhibition of
dopamine receptors interacted with the extinction-like effect.
D1 or D2 dopamine receptor agonist injection both increased
the initial (first hour) rate of responding and greatly reduced
the magnitude of the normal decline in responding from the
first to second hour compared with the control condition
(Figures 1D,E), essentially preventing the extinction-like effect.
In contrast, D1 or D2 antagonist injection reduced the response
rate in the first hour of the session to values indistinguishable
from those normally observed in the second hour, essentially
mimicking and/or accelerating extinction. One possibility is that
NAc core dopamine is part of the reinforcement mechanism that
prevents extinction. This idea is consistent with the proposed
role for dopamine as a reward prediction error signal, which
is thought to be the basis for learned changes in the neural
representation of value predicted by stimuli (Montague et al.,
1996; Schultz et al., 1997; Schultz, 1998). It is also consistent with
a role for dopamine in “reboosting” such value representations
(Berridge, 2012). On the other hand, dopamine agonists would be
expected to constitutively activate dopamine receptors, thereby
mimicking so-called “tonic” dopamine; although the agonists
would activate dopamine receptors at the time that reward is
delivered, they would also activate the receptors to a similar
degree at all other times. It is difficult to conceptualize how such
a constant signal could be interpreted as a prediction error or
as a “reboosting” signal that serves to indicate that a discrete
reinforcing event has occurred.
An alternative hypothesis is that the dopamine drugs did
not interfere with reinforcement, but with a neural mechanism
that directly activates cued approach behavior. This proposal is
supported by our previous studies demonstrating that a large
proportion (nearly half) of NAc neurons are excited by cues
in a DS task (Ambroggi et al., 2008; McGinty et al., 2013;
du Hoffmann and Nicola, 2014; Morrison and Nicola, 2014);
furthermore, in a cued receptacle approach task similar to the
one used here (i.e., without an operant response contingency), a
similar proportion of NAc neurons is excited (Caref and Nicola,
2014). Using video tracking, we established that these excitations
precede the onset of approach locomotion and predict the latency
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at which it will occur (McGinty et al., 2013; du Hoffmann and
Nicola, 2014; Morrison and Nicola, 2014). Moreover, injection
of dopamine antagonists into the NAc reduced the magnitude
of these excitations while impairing the ability to initiate cued
approach (du Hoffmann and Nicola, 2014). These results suggest
that dopamine directly facilitates the cue-evoked excitations
of NAc neurons that drive approach, perhaps by rendering
them more excitable in response to glutamatergic input (Nicola
et al., 2000, 2004; Hopf et al., 2003). Thus, treatment of NAc
neurons with dopamine receptor agonists may have increased
the probability of cued approach behavior by mimicking an
excitatory neuromodulatory effect of endogenous dopamine and
thereby increasing the magnitude of cue-evoked excitations.
Clustered Response Pattern May Be Due
to Fluctuations in Tonic Dopamine Levels
Another feature of the animals’ task performance is that
responses and non-responses to cues were not randomly
distributed, but appeared to be clustered into bursts of several
consecutive responses or non-responses. In the control (vehicle
injection or no injection) conditions, response clusters were
longer and more frequent toward the beginning of the session,
becoming shorter and less frequent toward session end; and
necessarily vice-versa for non-response clusters. This pattern
suggest that there are two states, responsive and non-responsive
(Figure 3), which fluctuate with a time course of minutes, and
which shift from an initial bias toward the responsive state
to a later bias toward the non-responsive state. Dopamine
agonist injection promoted the responsive state by decreasing
the probability of transitioning to the non-responsive state
(lengthening response clusters) and increasing the probability of
transitioning to the responsive state (shortening non-response
clusters), whereas antagonists had the opposite effect. The most
striking consequences of the agonist effects occurred in the
second hour of the session, when the drugs appear to have
prevented the normal increased bias toward the non-responsive
state: the second hour transition probabilities continued to
resemble those in the first hour rather than shifting toward
favoring the non-responsive state. In contrast, the antagonists
had their greatest effects in the first hour, when they caused the
transition probabilities to favor the non-responsive state, similar
to the transition probabilities normally occurring in the second
hour.
The effects of the dopamine agonists and antagonists on
transition probabilities are consistent with the hypothesis that
response state is a function of dopamine receptor occupation.
Thus, when NAc dopamine levels reach and exceed a threshold,
the animal is in the responsive state; below this threshold, the
animal is in the non-responsive state. Testing this hypothesis
would require measuring tonic dopamine levels as animals
perform this or a similar task; the hypothesis predicts that
dopamine levels should be higher during response clusters than
non-response clusters. Although to our knowledge previous
microdialysis studies have not examined whether fluctuations in
dopamine level correlate with local taxic approach probability,
a previous investigation found that NAc dopamine levels were
higher when food pellets were dropped into receptacles at 45 s
or 4 min intervals (both conditions likely necessitating taxic
approach to obtain the food on each trial) than when food
was freely available (a situation that minimizes the need for
taxic approach) (McCullough and Salamone, 1992). Studies that
have varied operant response rate requirements have produced
somewhat conflicting results, with some observing a positive
correlation between rate of operant responding and dopamine
level (McCullough et al., 1993; Sokolowski et al., 1998; Cousins
et al., 1999) and others finding exceptions to this proposed
relationship (Salamone et al., 1994; Cousins and Salamone,
1996; Ahn and Phillips, 2007; Ostlund et al., 2011). A potential
explanation for this discordance is that different operant tasks
engage the need for taxic approach to different degrees (Nicola,
2010); correlations with dopamine level may be more robust for
taxic approach probability than for operant response rate.
A related proposal is that tonic dopamine levels not only
drive faster rates of responding (or perhaps greater probability
of taxic approach), but also that dopamine levels are set by
the rate of reinforcement (Niv et al., 2005, 2007), an idea that
has recently gained experimental support (Hamid et al., 2016).
Accordingly, dopamine levels in animals working for nutritive
reinforcers should be lower in ad libitum-fed than in hungry
animals [as is in fact the case (Ostlund et al., 2011)], and lower
when the reinforcer is 3% sucrose than when it is an equivalent
volume of 10% sucrose. The proposed low dopamine levels in
3% sucrose could result in a chain reaction, with low dopamine
resulting in a low probability of responding to any given cue;
failures to respond in turn drives the reinforcement rate and
hence dopamine level still lower, and hence response probability
on the next cue presentation also becomes lower. The result
would be a progressive reduction in response rate similar to that
observed here.
Conclusions: Cued Taxic Approach Is a
Model for Investigation of Regulation of
Mesolimbic Dopamine by Nutrient State
The low dopamine-dependent response probability in ad libitum-
fed animals observed here is consistent with many recent
studies of regulation of dopamine neurons by messengers,
such as cholecystokinin, orexin, ghrelin, leptin, insulin and
glucagon-like peptide 1, that signal the body’s nutrient status
detected via various mechanisms. In general, signals that
report nutrient deficit increase dopamine neuronal activity,
whereas signals that report satiety or nutrient surfeit decrease
it (Ladurelle et al., 1997; Helm et al., 2003; Krügel et al.,
2003; Abizaid et al., 2006; Fulton et al., 2006; Hommel et al.,
2006; Narita et al., 2006; Kawahara et al., 2009; Leinninger
et al., 2009; Quarta et al., 2009, 2011; Jerlhag et al., 2010;
Perry et al., 2010; Domingos et al., 2011; España et al., 2011;
Skibicka et al., 2011, 2012a,b, 2013; Davis et al., 2011a,b;
Mebel et al., 2012; Patyal et al., 2012; Egecioglu et al.,
2013; Cone et al., 2014, 2015; Mietlicki-Baase et al., 2014).
The exquisite sensitivity of mesolimbic dopamine signaling
to nutrient state is consistent with the proposal that the
probability of mesolimbic dopamine-dependent behavior can
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change instantly as a result of the value, relative to the
nutrient state, of the reinforcer (Berridge, 2012). We observe
that low value reinforcers delivered to relatively sated animals
result in fluctuating response probabilities superimposed on
an overall decline in response probability. These observations,
coupled with the dramatic shifts in response and transition
probabilities produced by injection of dopamine agonists and
antagonists into the NAc, suggest that, under our conditions,
the dopamine level is held at low levels by nutrient sensing
mechanisms. The control of dopamine levels by these and
other parameters (such as recent reinforcement rate) may
produce dopamine levels that fluctuate around the threshold for
eliciting a response, causing cue responses and non-responses
to occur in clusters. The behavioral paradigm we use here—
mesolimbic dopamine-dependent sucrose-reinforced cued taxic
approach in ad libitum-fed animals—is therefore ideal for further
investigation of the regulation of dopamine dynamics by nutrient
state, reinforcement rate, and other parameters, and of the
mechanism by which these variables impact NAc dopamine-
dependent behavior.
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